E3Bio
E3Bio is focused on the efficient development of first in class drug candidates stimulating safe removal of cellular debris.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed E3Bio Information
Geographic Data
Address: Babraham
City: Cambridge
State: england
Zip: CB22 3AT
Country: GB
Financial Info
Stage:
series a
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Epsilon-3 Bio Ltd. is a preclinical stage company with investment from Index Ventures, Novo Ventures and Imperial Innovations. The company is focused on the efficient development of first in class drug candidates stimulating safe removal of cellular debris. Such agents are expected to provide a useful treatment for a wide range of diseases including inflammation and autoimmunity, neurodegeneration, fibrosis and cancer.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2012 | Series A | 3 | - |
Imperial Innovations Index Ventures Novo Ventures Imperial Innovations Index Ventures Novo Ventures |
1/2012 | Series A | 3 | - |
Imperial Innovations Index Ventures Novo Ventures Imperial Innovations Index Ventures Novo Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
